- Q1 organic sales decreased 0.4% to €1,249m (prior €1,317m).
- Taste, Nutrition & Health: organic +1.7% (reported €749m); Scent & Care: organic -3.4% (reported €500m).
- Care & Wellness declined in the low double digits, driven by a double-digit drop in UV filters.
- 2026 targets reaffirmed: organic sales growth 2.0-4.0%, adjusted EBITDA margin 21.5-22.5%, adjusted Business Free Cash Flow margin above 14.0%.
Overview
Symrise reported Q1 2026 organic sales down 0.4% to approximately €1,249m (prior €1,317m); Asia Pacific and the Americas saw positive organic growth while Europe, Africa & Middle East declined versus a strong prior-year period.
Segment performance
Taste, Nutrition & Health: organic +1.7%, reported €749m; Food & Beverage grew low-single-digit (Naturals & Savory mid-single-digit, Beverages low-single-digit); Pet Food grew low-single-digit while Pet Nutrition showed a slight organic decline with positive volumes. Scent & Care: organic -3.4%, reported €500m; Fragrance grew low-single-digit (Consumer mid-single-digit, Fine low-single-digit), Care & Wellness declined low-double-digits driven by a double-digit drop in UV filters, and Aroma Molecules fell mid-single-digits with some offset from Special Fragrance Ingredients.
ONE SYM Transformation
The ONE SYM Transformation program advanced, prioritizing portfolio focus, innovation, commercial excellence, scale realization and digitalization to capture structural cost savings and operational efficiencies and fund targeted reinvestment.
Outlook
Full-year 2026 guidance reaffirmed: organic sales growth 2.0–4.0%, adjusted EBITDA margin 21.5–22.5% and adjusted Business Free Cash Flow margin above 14.0%, assuming sequential improvement in organic growth during the year.
